Loading compound...
FGFR inhibitor
FUTIBATINIB is a small molecule drug that works as a Fibroblast growth factor receptor (FGFR) inhibitor. It is being studied for various types of cancer, including cholangiocarcinoma, soft tissue sarcoma, breast cancer, and hepatocellular carcinoma.
How it worksFUTIBATINIB works by blocking a specific protein called the Fibroblast growth factor receptor, which can help stop the growth of certain cancer cells.
Used for
CholangiocarcinomaSoft tissue sarcomaBreast cancerHepatocellular carcinomaNon-small cell lung carcinomaOther neoplasms
Conditions
CholangiocarcinomaBiliary tract neoplasmSoft tissue sarcomaBreast cancerHepatocellular carcinomaNon-small cell lung carcinoma
Class
FGFR inhibitorSmall moleculeOncology
How to take
FormsOral
RoutesOral
Talk to your doctor
Questions to ask
- ·How will FUTIBATINIB affect my specific type of cancer?
- ·What are the common side effects of this FGFR inhibitor?
- ·Are there any interactions with my current medications?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.